The government is considering easing export curbs on certain active pharmaceutical ingredients (APIs), an official said.
The issue was discussed in detail in a high-level meeting at cabinet secretariat, the official added.
Before easing the curbs, the government is looking at parameters such as availability of adequate stock to cater to local demand, production level, future requirements, and India's multilateral commitments.
On March 3, exports of 26 APIs and formulations, including paracetamol, vitamin B1 and B12, were put under restricted category amid the coronavirus outbreak.
Certain players from pharma sector have raised concerns over these restrictions, under which exporters require a licence from the commerce ministry to undertake outbound shipments.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app